Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer von Fletcher, Claire E., Sulpice, Eric, Combe, Stephanie, Shibakawa, Akifumi, Leach, Damien A., Hamilton, Mark P., Chrysostomou, Stelios L., Sharp, Adam, Welti, Jon, Yuan, Wei, Dart, Dafydd. A., Knight, Eleanor, Ning, Jian, Francis, Jeffrey C., Kounatidou, Evangelia E., Gaughan, Luke, Swain, Amanda, Lupold, Shawn E., de Bono, Johann S., McGuire, Sean E., Gidrol, Xavier, Bevan, Charlotte L.

Volltext

Abstract 1796: Repurposing CRISPR to study aberrant AR signaling in models of castration-resistant prostate cancer von Kounatidou, Evangelia E., Robson, Craig, Gaughan, Luke

Volltext

A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities von Kounatidou, Evangelia, Nakjang, Sirintra, McCracken, Stuart R C, Dehm, Scott M, Robson, Craig N, Jones, Dominic, Gaughan, Luke

Volltext

Ex vivo gene modification therapy for genetic skin diseases—recent advances in gene modification technologies and delivery von Jayarajan, Vignesh, Kounatidou, Evangelia, Qasim, Waseem, Di, Wei‐Li

Volltext